Table 5 Evaluation of SNPs in clinical isolates.

From: Use of next generation sequence to investigate potential novel macrolide resistance mechanisms in a population of Moraxella catarrhalis isolates

Genes_SNPs

Single-base mutation

Verification in clinical isolates (Resistant isolates [R], n = 21; Susceptible isolates [S], n = 52)

P value

rumA_619

C− > T

R: 10/21 S: 2/52

<0.0001

rplF_140

T− > C

R: 8/21 S: 1/52

<0.0001

MCR_0020_643

G− > A

R: 8/21 S: 0/52

<0.0001

MCR_1465_270

T− > G

R: 4/21 S: 0/52

0.0055

copB_1348

C− > A

R: 9/21 S: 8/52

0.0292

rrmA_238

G− > A

R: 6/21 S: 2/52

0.0058

23S rRNA_2330

A− > T

R: 21/21 S: 0/52

<0.0001

23S rRNA_2480

C− > T

R: 13/21 S: 0/52

<0.0001

23S rRNA_2144

A− > T

R: 3/21 S: 0/52

0.0214

MCR_0016_1249

A− > G

R: 3/21 S: 2/52

0.1395

MCR_1465_695

G− > A

R: 13/21 S: 31/52

1.0000

copB_1205

A− > C

R: 15/21 S: 23/52

0.0680